Blog

Expert Discusses Promise of Immunotherapy in Genitourinary Cancers – OncLive


OncLive

Expert Discusses Promise of Immunotherapy in Genitourinary Cancers
OncLive
In the treatment of genitourinary (GU) cancers, immunotherapy continues to move toward the frontline setting. Charles Drake, MD, PhD, says he is optimistic about the future of immunotherapy, as trials are showing promising results in various GU cancers

2017-03-08 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.